Clinical Trial Update: Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) [NA]

View source ↗

Summary

A completed clinical trial evaluated the combination of tacrolimus (FK506) with mycophenolate mofetil (MMF) in lupus nephritis to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Prograf (Tacrolimus)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Lupus Nephritis | NA | Status: COMPLETED